U.S. appeals court reinstates Rezulin lawsuit Reuters.com: "U.S. appeals court reinstates Rezulin lawsuit
Thu Oct 5, 2006 6:34pm ET
Market View
PFE (Pfizer Inc )
Last:$27.68
Change: -0.42 (-1.49%)
Revenue (ttm):$47,298.0M
EPS:1.41
Market Cap:$204,889.80M
Time:8:00pm ET



Stock Details
Company Profile
Analyst Research
Company News:
PRESS DIGEST - New York Times business - Oct 20
UPDATE 2-Profit rises at Pfizer and three other drugmakers
More Company News...
At the Helm:
Jeffrey Kindler
Vice Chairman of the Board, Chief Executive Officer

Salary: USD 902,200
Bonus: USD 1,000,000
Age: 51

Mr. Kindler is Pfizer Inc's Vice Chairman and General Counsel since March 2005 and was named to the additional post of Chief Executive Officer in July... Full Bio

Full Management Team
Insider Trading Email This Article Print This Article Reprints [-] Text [+] NEW YORK, Oct 5 (Reuters) - A federal appeals court in New York on Thursday reinstated a lawsuit filed against Pfizer Inc. (PFE.N: Quote, Profile, Research) unit Warner-Lambert by people who claim to have been harmed by its withdrawn diabetes drug Rezulin.
In a 22-page opinion, a three-judge panel for the U.S. Court of Appeals for the Second Circuit wrote that a lower court judge had wrongly concluded that federal law preempted claims made under a Michigan state product liability statute.
The lawsuit, filed by residents of Michigan who said their various injuries were caused by Rezulin, had been dismissed by U.S. District Judge Lewis Kaplan in 2005.
Rezulin was "